AtriCure(ATRC) - 2025 Q2 - Earnings Call Presentation

AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025 July 29, 2025 MASON, Ohio--(BUSINESS WIRE)--Jul. 29, 2025-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2025 financial results. "Our stellar results reflect the power of innovation and the growing impact of our expanding portfolio, particul ...